SYNH On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt

syneos health inc (SYNH) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SYNEOS HEALTH INC (SYNH)
\

Related News

No related news articles were found.

syneos health inc (SYNH) Related Businessweek News

No Related Businessweek News Found

syneos health inc (SYNH) Details

Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services, including medication adherence, communications, and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.

24,000 Employees
Last Reported Date: 03/18/19
Founded in 2010

syneos health inc (SYNH) Top Compensated Officers

CEO & Director
Total Annual Compensation: $1.5M
Chief Financial Officer
Total Annual Compensation: $654.2K
President of Clinical Development for Therape...
Total Annual Compensation: $995.9K
General Counsel & Corporate Secretary
Total Annual Compensation: $362.6K
Consultant
Total Annual Compensation: $56.3K
Compensation as of Fiscal Year 2018.
syneos health inc
Syneos Health Appoints Patrick Nealon as Executive Vice President and General Manager of Oncology Clinical Development

Syneos Health announced the appointment of Patrick Nealon as Executive Vice President and General Manager of Oncology Clinical Development. In this role, the Boston-based executive will oversee the company’s clinical oncology operations. An industry veteran with 30 years of expertise across pharmaceutical, biotech and medical device sectors, Nealon has spent the last 18 years focused on developing and commercializing oncology assets. He’s gained deep therapeutic expertise across all phases of drug development in increasingly complex and significant oncology-focused roles, most recently as Head of Global Program Management for Oncology at Servier Pharmaceuticals, Head of Global Program Management, Hematology and Oncology at Shire, and Head of Program Management, Hematology at Baxalta.

Syneos Health, Inc. Presents at Jefferies 2019 Healthcare Conference, Jun-05-2019 10:30 AM

Syneos Health, Inc. Presents at Jefferies 2019 Healthcare Conference, Jun-05-2019 10:30 AM. Venue: Grand Hyatt, 109 E 42nd St, New York, New York, United States. Speakers: Alistair Macdonald, CEO & Director.

Syneos Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019

Syneos Health, Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was USD 1,119.006 million compared to USD 1,057.196 million a year ago. Operating income was USD 26.816 million compared to USD 10.175 million a year ago. Net loss was USD 30.004 million compared to USD 24.552 million a year ago. Basic loss per share was USD 0.29 compared to USD 0.24 a year ago.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

SYNH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SYNH.
View Industry Companies
 

Industry Analysis

SYNH

Industry Average

Valuation SYNH Industry Range
Price/Earnings 100.0x
Price/Sales 1.1x
Price/Book 1.7x
Price/Cash Flow 17.2x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SYNEOS HEALTH INC, please visit www.syneoshealth.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.